• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MiR-506-3p通过靶向GALNT4在前列腺癌中作为一种新型肿瘤抑制因子发挥作用。

MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.

作者信息

Hu C-Y, You P, Zhang J, Zhang H, Jiang N

机构信息

Department of Urology, Gongli Hospital Affiliated to The Second Military Medical University, Shanghai, China.

出版信息

Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5133-5138. doi: 10.26355/eurrev_201906_18177.

DOI:10.26355/eurrev_201906_18177
PMID:31298366
Abstract

OBJECTIVE

Researches have indicated that microRNA-506-3p (miR-506-3p) was downregulated and functioned as tumor suppressor in cancers. However, the biological role of miR-506-3p in prostate cancer (PCa) remains to be elucidated.

MATERIALS AND METHODS

Expression of miR-506-3p in PCa cell lines was measured by qRT-PCR. Effects of miR-506-3p expression on PCa cell behaviors were investigated with MTT assay, colony formation assay, and transwell invasion assay. Connection of miR-506-3p and N-Acetylgalactosaminyltransferase-4 (GALNT4) was analyzed with luciferase activity reporter assay and Western blot assay.

RESULTS

miR-506-3p expression was downregulated in PCa cell lines. Function studies demonstrated that overexpression of miR-506-3p inhibits PCa tumor progression in vitro. Mechanistic investigations found GALNT4 was a direct target of miR-506-3p. Overexpression of GALNT4 reversed the tumor-suppressive effects of miR-506-3p on PCa cell.

CONCLUSIONS

Our results elucidated genetic silencing of miR-506-3p enhances GALNT4 oncogene expression to accelerate PCa progression.

摘要

目的

研究表明,微小RNA-506-3p(miR-506-3p)在癌症中表达下调并发挥肿瘤抑制作用。然而,miR-506-3p在前列腺癌(PCa)中的生物学作用仍有待阐明。

材料与方法

采用qRT-PCR检测miR-506-3p在PCa细胞系中的表达。通过MTT法、集落形成试验和Transwell侵袭试验研究miR-506-3p表达对PCa细胞行为的影响。用荧光素酶活性报告试验和蛋白质印迹试验分析miR-506-3p与N-乙酰半乳糖胺基转移酶-4(GALNT4)的关系。

结果

miR-506-3p在PCa细胞系中表达下调。功能研究表明,miR-506-3p的过表达在体外抑制PCa肿瘤进展。机制研究发现GALNT4是miR-506-3p的直接靶点。GALNT4的过表达逆转了miR-506-3p对PCa细胞的肿瘤抑制作用。

结论

我们的结果表明,miR-506-3p的基因沉默增强了GALNT4癌基因的表达,从而加速了PCa的进展。

相似文献

1
MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.MiR-506-3p通过靶向GALNT4在前列腺癌中作为一种新型肿瘤抑制因子发挥作用。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5133-5138. doi: 10.26355/eurrev_201906_18177.
2
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.拟肿瘤抑制因子 miR-1-3p 通过抑制 E2F5 和 PFTK1 来调节前列腺癌细胞的侵袭性。
J Exp Clin Cancer Res. 2018 Sep 5;37(1):219. doi: 10.1186/s13046-018-0895-z.
3
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.染料木黄酮上调前列腺癌中的肿瘤抑制 microRNA-574-3p。
PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.
4
miR-326 functions as a tumor suppressor in human prostatic carcinoma by targeting Mucin1.miR-326 通过靶向黏蛋白 1 发挥抑癌作用,抑制人前列腺癌的发生。
Biomed Pharmacother. 2018 Dec;108:574-583. doi: 10.1016/j.biopha.2018.09.053. Epub 2018 Sep 20.
5
miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.miR-490-3p 通过调控组蛋白去乙酰化酶 2 来调节前列腺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):539-546. doi: 10.26355/eurrev_201901_16866.
6
MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.miR-487a-3p 通过靶向 CCND1 在前列腺癌中发挥新的肿瘤抑制作用。
J Cell Physiol. 2020 Feb;235(2):1588-1600. doi: 10.1002/jcp.29078. Epub 2019 Jul 15.
7
MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.微小 RNA-373-3p 通过靶向 AKT1 抑制前列腺癌进展。
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6252-6259. doi: 10.26355/eurrev_201810_16032.
8
MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.微小RNA-655-3p通过调节肝细胞癌中的ADAM10和β-连环蛋白通路发挥肿瘤抑制作用。
J Exp Clin Cancer Res. 2016 Jun 4;35(1):89. doi: 10.1186/s13046-016-0368-1.
9
miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.miR-15a-3p 通过下调 Wnt/β-连环蛋白信号通路靶向 SLC39A7 抑制前列腺癌细胞增殖和侵袭。
Cancer Biother Radiopharm. 2019 Sep;34(7):472-479. doi: 10.1089/cbr.2018.2722. Epub 2019 May 24.
10
MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.miR-299-3p 通过靶向 TCF4 抑制宫颈癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5621-5627. doi: 10.26355/eurrev_201907_18296.

引用本文的文献

1
Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications.微小RNA-506在癌症治疗中的治疗潜力:作用机制及治疗意义
Front Oncol. 2025 Apr 3;15:1524763. doi: 10.3389/fonc.2025.1524763. eCollection 2025.
2
CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.环状 RNA NRCAM 通过上调 NRCAM 促进甲状腺乳头状癌的进展。
J Endocrinol Invest. 2024 May;47(5):1215-1226. doi: 10.1007/s40618-023-02241-x. Epub 2024 Mar 14.
3
BarH-Like Homeobox 2 Suppresses Cell Proliferation, Invasion, and Angiogenesis in Hepatocellular Carcinoma by Activating N-Acetylgalactosaminyltransferase 4.
BarH 样同源盒 2 通过激活 N-乙酰氨基半乳糖胺转移酶 4 抑制肝癌细胞增殖、侵袭和血管生成。
Mol Biotechnol. 2024 Nov;66(11):3226-3237. doi: 10.1007/s12033-023-00930-9. Epub 2023 Nov 13.
4
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions.糖基化与非编码 RNA 在癌症及其他生理病理条件下的相互关系。
Int J Mol Sci. 2022 Dec 13;23(24):15804. doi: 10.3390/ijms232415804.
5
miR-506-3p Relieves Neuropathic Pain following Brachial Plexus Avulsion via Mitigating Microglial Activation through Targeting the CCL2-CCR2 Axis.miR-506-3p 通过靶向 CCL2-CCR2 轴减轻小胶质细胞激活缓解臂丛神经根撕脱伤后的神经病理性疼痛。
Dev Neurosci. 2023;45(1):37-52. doi: 10.1159/000528450. Epub 2022 Dec 5.
6
Bone-Metabolism-Related Serum microRNAs to Diagnose Osteoporosis in Middle-Aged and Elderly Women.用于诊断中老年女性骨质疏松症的骨代谢相关血清微小核糖核酸
Diagnostics (Basel). 2022 Nov 19;12(11):2872. doi: 10.3390/diagnostics12112872.
7
CircPTK2 accelerates tumorigenesis of colorectal cancer by upregulating AKT2 expression via miR-506-3p.环状 RNA 蛋白酪氨酸激酶 2 通过 miR-506-3p 上调 AKT2 表达促进结直肠癌的发生。
Kaohsiung J Med Sci. 2022 Nov;38(11):1060-1069. doi: 10.1002/kjm2.12589. Epub 2022 Sep 26.
8
Identification of 5 microRNA biomarkers associated with the prognosis of uveal melanoma.鉴定与葡萄膜黑色素瘤预后相关的 5 个 microRNA 生物标志物。
Medicine (Baltimore). 2022 Sep 2;101(35):e30366. doi: 10.1097/MD.0000000000030366.
9
YY1 accelerates oral squamous cell carcinoma progression through long non-coding RNA Kcnq1ot1/microRNA-506-3p/SYPL1 axis.YY1 通过长非编码 RNA Kcnq1ot1/miRNA-506-3p/SYPL1 轴加速口腔鳞状细胞癌的进展。
J Ovarian Res. 2022 Jul 1;15(1):77. doi: 10.1186/s13048-022-01000-5.
10
Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.雄激素调控与前列腺腺泡腺癌中 microRNAs 的相关性研究。
Genes (Basel). 2022 Mar 30;13(4):622. doi: 10.3390/genes13040622.